We developed an hybrid organic-inorganic composite consisting of a 2D perovskite and a copolymer. At room temperature the composite is highly transparent in the visible region with transmittance > 90%. At higher temperatures, the movement of the polymer chains releases the precursors, allowing the perovskite formation, which results in a colored film. The color changes according to the ‘n’ value of the PVK. PVK with n=1 starts coloring at 70°C, achieving a ∆Tmax = 91.5% at 510 nm.
Technologies
In this section it is possible to view, also through targeted research, the technologies inserted in the PROMO-TT Database. For further information on the technologies and to contact the CNR Research Teams who developed them, it is necessary to contact the Project Manager (see the references at the bottom of each record card).
Displaying results 1 - 4 of 4
The invention is a synthetic method to prepare colloidal nanomaterials of V-VI-VII semiconductors that do not contain toxic elements. This is the first method for the synthesis of mixed anion nanomaterials without toxic elements at large, which permitted to obtain, among others, bismuth chalcohalide nanocrystals that are arguably considered as one of main candidates to be the next big thing for light energy conversion.
The proposed technology is about the development of an innovative sunscreen obtained from cod fish bones, according to the principles of the circular economy. The sunscreen is a reddish powder, which is constituted of hydroxyapatite (a calcium phosphate main component of human bones) modified with iron. It is prepared with a simple and easily scalable process (treatment of the bones in Fe solution and successively at T = 700 oC) and could be adapted for bones of other fishes.
Our treatment demonstrated the ability to kill metastatic human melanoma cells, for which there are very few effective therapeutic approaches. Use of a specific Essential Oil (EO) to inhibit the replication of human metastatic melanoma cells. This EO can be used both for direct application to the skin, and administered by mouth to reach both primary and metastatic melanomas.